Efficacy of Two Regimens for Colon Cleansing Using Polyethylene Glycol 4000: A Randomized Open Label Trial

Phan Thi Hien1, Vu Huu Thoi2, Nguyen Thu Ha3

  • 1Vietnam National Children's Hospital, Dong Da district, Hanoi city, Vietnam. Correspondence to: Dr Phan Thi Hien, Vietnam National Children's Hospital, 18/879 La Thanh road, Dong Da district, Hanoi city, Vietnam. phanthihienns@gmail.com.

Indian Pediatrics
|May 28, 2021
PubMed

Insights

Polyethylene glycol (PEG) with bisacodyl offers better tolerance for pediatric colon cleansing compared to PEG with a glycerol enema, with both regimens demonstrating high effectiveness and safety for colonoscopy preparation.

Area of Science:

  • Pediatric Gastroenterology
  • Endoscopic Procedures
  • Pharmacology

Background:

  • Effective colon cleansing is crucial for successful pediatric colonoscopy.
  • Polyethylene glycol (PEG) based regimens are commonly used for bowel preparation in children.
  • Comparing different PEG formulations and adjuncts is important for optimizing pediatric care.

Purpose of the Study:

  • To compare the effectiveness, safety, and tolerance of two distinct colon cleansing regimens in pediatric patients undergoing colonoscopy.
  • Specifically, to evaluate a regimen of PEG with electrolyte plus oral bisacodyl (PEG+B) against a regimen of PEG with electrolyte plus a glycerol enema (PEG+G).

Main Methods:

  • A prospective, randomized, open clinical trial involving 129 children aged 3 to 18 years.
  • Participants were randomized to receive either PEG with electrolyte and oral bisacodyl or PEG with electrolyte and a glycerol enema.
  • Colon cleansing success rates, laboratory values, and adverse events (nausea, bloating) were assessed.

Main Results:

  • Both PEG+B and PEG+G regimens demonstrated high colon cleansing effectiveness (93.8% vs 89.1%, P=0.51).
  • No significant differences in pre- and post-regimen laboratory values were observed between the groups.
  • The PEG+G group experienced significantly higher rates of nausea (65.6% vs 31.3%) and bloating (50% vs 17.2%) compared to the PEG+B group (P<0.001 for both).

Conclusions:

  • Both polyethylene glycol-based colon cleansing regimens are effective and safe for pediatric use.
  • The PEG with bisacodyl regimen showed superior tolerance, with significantly lower incidence of nausea and bloating in children.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
426
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
389
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
657
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
410
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
372
Endoscopic Procedures II: Colonoscopy01:25

Endoscopic Procedures II: Colonoscopy

The colon, or large intestine, is the final segment of the digestive system. Its primary functions include absorbing water and vitamins produced by gut bacteria and transforming waste from liquid to solid to form stool. In adults, the large intestine is approximately 5 feet long and consists of four main sections:
302